Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ultragenyx Pharmaceutical (RARE) Minority Interest (2024 - 2025)

Historic Minority Interest for Ultragenyx Pharmaceutical (RARE) over the last 2 years, with Q3 2025 value amounting to $7.0 million.

  • Ultragenyx Pharmaceutical's Minority Interest changed 0.0% to $7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.0 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $7.0 million for FY2024, which is N/A changed from last year.
  • As of Q3 2025, Ultragenyx Pharmaceutical's Minority Interest stood at $7.0 million, which was down 0.0% from $7.0 million recorded in Q2 2025.
  • In the past 5 years, Ultragenyx Pharmaceutical's Minority Interest registered a high of $7.0 million during Q3 2024, and its lowest value of $7.0 million during Q3 2024.